Background: Distal embolism is one of the major complications during percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). These complications may be potentially mitigated by distal protection. The GuardWire system (GS) consists of an occlusion balloon which is inflated distally allowing 'protected' PCI has recently become available. Aim: To evaluate the efficacy and safety of this device, we studied a total of 212 patients (male 69.8%) of AMI who underwent PCI using GS. The GS was successfully placed in all of the cases. Gross inspection of the filter after retrieval demonstrated macroscopic emboli including thrombus in 93.9% of patients. Results: See table.
Background: TIMI myocardial perfusion grade (MPG) reflects the integrity of microvasculature. We hypothesized that a combined analysis of MPG before and after PCI in AMI may reveal information on further recovery of left ventricular (LV) function. Methods: We evaluated 585 consecutive patients (pts, age 58,7±11 y) with ST-segment elevation AMI treated with PCI. Myocardial injury was expressed as area under the curve of CK-MB release in the first 48 hours (AUC). MPG was evaluated before and after PCI. The sum of ST-segment elevation (12-lead ECG) was obtained before and 30 minutes after PCI. LV Ejection fraction (EF) was evaluated by 2D echocardiography at 24 hours and 6 months after PCI. Results: Evaluation of MPG before and after PCI showed 6 different reperfusion patterns; I -MPG-0/1 before and after PCI, II -severe MPG deterioration (from 2/3 to 0/1), III -MPG improvement from grade 0/1 to 2, IV -mild MPG deterioration (from 2/3 to 2), V -MPG improvement from 0/1 to 3, VI -high MPG maintained (2/3 before and 3 after PCI). Results for AUC, proportion of pts with complete (>70%) ST resolution, and EF at 24h and 6mo by the reperfusion pattern are shown in the table. Concusion: Maintaining a high MPG throughout PCI in AMI or achieving a marked MPG improvement are both related to a mild, largely reversible, myocardial injury and implicate recovery of LV function. In contrast, lack of improvement of a poor MPG or severe deterioration of MPG are associated with a major myocardial injury and lack of LV function recovery at 6 months.
1003-92
Relationship Between Acute Background: Previous studies have reported that acute hyperglycemia is associated with adverse outcomes after acute myocardial infarction (AMI). The aim of this study was to examine the relationship between acute hyperglycemia and microvascular injury after primary coronary angioplasty for AMI. Methods: We studied 106 patients with a first anterior wall AMI who underwent primary coronary angioplasty within 12 h of onset. Coronary flow velocity parameters were assessed immediately after reperfusion using a Doppler guidewire. We evaluated the presence of systolic flow reversal (SFR), diastolic deceleration time (DDT), and coronary flow reserve (CFR) as markers of microvascular injury. We defined severe microvascular injury as the presence of SFR and DDT <600 ms. Results: Acute hyperglycemia, defined as a blood glucose level of >190 mg/dl at admission, was found in 35 patients (33%). In patients with acute hyperglycemia, the presence of SFR was more frequent, DDT was shorter, and CFR was lower. By regression analysis, the blood glucose level significantly correlated with DDT (r=0.43, p<0.0001). Multivariate analysis showed that acute hyperglycemia was an independent determinant of severe microvascular injury (odds ratio 7.36, p=0.015). Conclusions: Acute hyperglycemia is related to severe microvascular injury, resulting in larger infarct size and worse left ventricular function. This may partly account for adverse outcomes after AMI in patients with acute hyperglycemia. , as >50% recovery from peak ST levels lasting >4 hrs (minutes); 2) extent of ST recovery (>70%ST) as >70% recovery from peak ST levels at STABLE (%yes); 3) 3 hr ST deviation vs. time trend curve area (AREA) in uV-min; 4) late ST re-elevation (LATE) of >150uV over baseline after STABLE (%yes). Mortality and major adverse cardiovascular endpoints (MACE) of death, re-MI, new CHF and urgent CABG were defined by each trial's coordinating center, blinded to ST data. Core lab ST analyses were blinded to outcomes. Results: MACE of 13.3% and 17.2% was seen with lytics and stenting, respectively. ST endpoints were:
1003-93 Outcomes Prediction With Continuous 12-Lead STSegment Recovery in ST Elevation
Conclusions:Considering differences in pt population size in stent and lytics groups, continuous ST-segment recovery endpoints are essentially equally predictive of outcome in STEMI pts undergoing either medical or mechanical intervention.
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